Alexander Maximilian Aldejohann

7PUBLICATIONS
21CO-AUTHORS
Medical bacteriologyMedical infection agents (incl. prions)Biological adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 20, 2026
Ergosterol-depleted clinical isolates of Nakaseomyces glabratus can develop multi-drug resistance without severe fitness defects or attenuated virulence in an invertebrate infection model.

|Oct 28, 2025
Correction: Aldejohann et al. Catastrophic Cerebral Infarctions in a Pediatric Patient with Acute Lymphoblastic Leukemia Due to Mucorales Infection. J. Fungi 2025, 11, 618.

Alexander M Aldejohann, Antonio Uribe Munoz, Miriam A Füller

|Sep 26, 2025
Localized Versus Diffuse Corneal Invasion in Fungal Keratitis: Histological Insights from Candida albicans and Fusarium falciforme.

Johanna Theuersbacher, Lukas Haug, Alexander Maximilian Aldejohann

|Sep 26, 2025
Catastrophic Cerebral Infarctions in a Pediatric Patient with Acute Lymphoblastic Leukemia Due to Mucorales Infection.

Alexander M Aldejohann, Antonio Uribe Munoz, Miriam A Füller

|May 15, 2025
In vitro activity of novel antifungals, natamycin, and terbinafine against Fusarium.

Enrico Garbe, Ahsan Ullah, Alexander Maximilian Aldejohann

|Jan 11, 2024
In vitro activity of ibrexafungerp against clinically relevant echinocandin-resistant Candida strains.

Alexander Maximilian Aldejohann, Carolina Menner, Nadja Thielemann

Pageof 2

Frequent Collaborators

2 joint publications

Ronny Martin

2 joint publications

Andreas H Groll

2 joint publications

Oliver Kurzai

2 joint publications

Antonio Uribe Munoz